# A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination

**Authors:** Damien P. Kuffler, Onix Reyes, Ivan J. Sosa, Christian A. Foy

PMC · DOI: 10.3389/ebm.2026.10907 · Experimental Biology and Medicine · 2026-03-13

## TL;DR

A new platelet-rich plasma treatment rapidly and permanently eliminates chronic nerve pain, outperforming traditional autograft methods.

## Contribution

A novel PRP formulation directly and rapidly eliminates chronic neuropathic pain without requiring target reinnervation.

## Key findings

- PRP repairs eliminated chronic neuropathic pain in all patients within 2 months.
- Pain reduction with PRP occurred rapidly, without waiting for axon reinnervation.
- Autografts showed delayed and partial pain elimination compared to PRP.

## Abstract

Peripheral nerve trauma results in 50%–84% of patients developing chronic neuropathic pain, which is eliminated when axons reinnervate targets. Autografts reduce pain by promoting target reinnervation. We hypothesized that applying a novel platelet-rich plasma (PRP) formulation to proximal stumps would permanently eliminate the pain. This prospective case series compared analgesia levels after bridging nerve gaps with an autograft (autograft repair) vs. a PRP-filled collagen tube (PRP repair). Autograft repairs were performed on 16 nerves with a 5.75-cm mean gap length, 2.0-year repair delay, 42.3-year age, and 8.6 chronic neuropathic pain. PRP repairs were performed on 10 nerves with a 6.0-cm gap length, 1-year repair delay, 36.7-year age, with 88% having 9.1 chronic neuropathic pain. For autograft repairs, the pain began to decrease when axons reinnervated targets, reaching a mean of 0.3 in 18.2% of patients, and was eliminated in 81.8%. Following PRP repairs, the pain reduction began within 2 weeks and was eliminated by 2 months. Thus, autografts contribute to pain reduction/elimination by promoting target reinnervation. However, PRP directly and rapidly induced long-term pain elimination in all patients, while axons were regenerating, and without target reinnervation. These results prove that platelet-released factors reliably and rapidly eliminate chronic neuropathic pain.

## Full-text entities

- **Diseases:** Peripheral nerve trauma (MESH:D010523), neuropathic pain (MESH:D009437), pain (MESH:D010146)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13021564/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13021564/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC13021564/full.md

---
Source: https://tomesphere.com/paper/PMC13021564